Combined metformin and simvastatin therapy inhibits SREBP2 maturation and alters energy metabolism in glioma
Abstract This study aims to explore the inhibitory effects of combined metformin and simvastatin therapy on the malignant progression of glioma. The research specifically examines how the maturation of SREBP2 as a transcription factor affects the expression of GLUT1 and GLUT6 in glioma cells. Additi...
        Saved in:
      
    
          | Main Authors: | Xiaolong Qiao, Zixuan Wang, Yinan Chen, Nan Peng, Hongwei Zhang, Chaoshi Niu, Chuandong Cheng | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Nature Publishing Group
    
        2024-11-01 | 
| Series: | Cell Death and Disease | 
| Online Access: | https://doi.org/10.1038/s41419-024-07169-5 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Cholesterol metabolism regulator SREBP2 inhibits HBV replication via suppression of HBx nuclear translocation        
                          
 by: Fan Yang, et al.
 Published: (2025-01-01)
- 
                
                    The Mutual Inhibition of FoxO1 and SREBP-1c Regulated the Progression of Hepatoblastoma by Regulating Fatty Acid Metabolism        
                          
 by: Yu Hu, et al.
 Published: (2021-01-01)
- 
                
                    The Combined Inhibition of SREBP and mTORC1 Signaling Synergistically Inhibits B‐Cell Lymphoma        
                          
 by: Zhenhan Zhu, et al.
 Published: (2024-11-01)
- 
                
                    Effects of Simvastatin on Glucose Metabolism in Mouse MIN6 Cells        
                          
 by: Jieqiong Zhou, et al.
 Published: (2014-01-01)
- 
                
                    Advances in the treatment of glioma-related signaling pathways and mechanisms by metformin        
                          
 by: Xingyuan Ma, et al.
 Published: (2025-01-01)
 
       